William Ho
2022 - RAPT Therapeutics
In 2022, William Ho earned a total compensation of $1.4M as Chief Medical Officer at RAPT Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $145,000 |
|---|---|
| Option Awards | $809,275 |
| Salary | $445,000 |
| Total | $1,399,275 |
Ho received $809.3K in option awards, accounting for 58% of the total pay in 2022.
Ho also received $145K in non-equity incentive plan and $445K in salary.
Rankings
In 2022, William Ho's compensation ranked 2,374th out of 5,753 executives tracked by ExecPay. In other words, Ho earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,374 out of 5,753 | 59th |
Division Manufacturing | 1,303 out of 3,133 | 58th |
Major group Chemicals And Allied Products | 578 out of 1,419 | 59th |
Industry group Drugs | 533 out of 1,320 | 60th |
Industry Pharmaceutical Preparations | 385 out of 966 | 60th |
Source: SEC filing on April 7, 2023.
Ho's colleagues
We found two more compensation records of executives who worked with William Ho at RAPT Therapeutics in 2022.
News
RAPT Therapeutics CEO Brian Wong's 2023 pay jumps 26% to $6.6M
April 5, 2024
RAPT Therapeutics CEO Brian Wong's 2022 pay jumps 84% to $5.2M
April 7, 2023
IN8BIO CEO William Ho's 2021 pay jumps 51% to $2.3M
April 22, 2022
RAPT Therapeutics CEO Brian Wong's 2021 pay falls 21% to $2.8M
April 11, 2022
RAPT Therapeutics CEO Brian Wong's 2020 pay jumps 86% to $3.6M
April 15, 2021
RAPT Therapeutics CFO Rodney Young receives $2.3M in 2019
April 29, 2020